Scientists have uncovered a potential drug combo that may supercharge popular weight-loss treatments for older women.
In a small retrospective study of women taking varying doses of tirzepatide for weight loss, after 15 months of treatment, participants who were also using menopausal hormone therapy experienced 35 percent more total bodyweight loss than those not using hormone therapy.
For the research, scientists at the Mayo Clinic and Wayne State University in the US gathered health data from 120 women, the majority of whom were White, and in their 50s.
Eighty of the participants only used tirzepatide for weight loss, and 40 used tirzepatide as well as any type of menopausal hormone therapy, with data tracking their health for an average of 18 months.
Read Full Article Here
